| Literature DB >> 6744901 |
Abstract
Disruption of cholinergic neurotransmission may result in memory impairment. In this study the anticholinergic drug, trihexyphenidyl, at low doses when administered chronically for one month to Parkinson disease patients caused a decrease in performance on recent but not immediate memory tests. Awareness of possible deterioration of memory function of parkinsonian patients on anticholinergic medication is necessary.Entities:
Mesh:
Substances:
Year: 1984 PMID: 6744901 DOI: 10.1016/s0010-9452(84)80051-9
Source DB: PubMed Journal: Cortex ISSN: 0010-9452 Impact factor: 4.027